Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 7, 2022; 28(37): 5444-5456
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5444
Table 5 Cox proportional hazard multivariate analysis for mortality in patients with metabolic associated fatty liver disease according to the LFN-COVID-19 index

OR
B coefficient
P value
95%CI
LFN-COVID-19 index0.241-1.4220.0130.079-0.741
PaO2/FiO2 ratio1.0000.0000.8770.996-1.004
Neutrophil/lymphocyte ratio1.0430.0420.0301.004-1.083
Creatine phosphokinase1.0010.0010.3400.999-1.002
Body mass index in kg/m21.0930.0890.0021.033-1.157

  • Citation: Macías-Rodríguez RU, Solís-Ortega AA, Ornelas-Arroyo VJ, Ruiz-Margáin A, González-Huezo MS, Urdiales-Morán NA, Román-Calleja BM, Mayorquín-Aguilar JM, González-Regueiro JA, Campos-Murguía A, Toledo-Coronado IV, Chapa-Ibargüengoitia M, Valencia-Peña B, Martínez-Cabrera CF, Flores-García NC. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19. World J Gastroenterol 2022; 28(37): 5444-5456
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i37/5444.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i37.5444